Vineet LaboratoriesNSE:VINEETLAB -1.94%38 Days Payable is 265.37 as of Dec. 2025, which is 153% above its 10-year median of 104.85. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 38/100 and a GF Value™ of ₹15.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,556 Chemicals companies, Vineet Laboratories ranks better than 94.92% on this metric.
The historical rank and industry rank for Vineet Laboratories's Days Payable or its related term are showing as below:
NSE:VINEETLAB'
s Days Payable Range Over the Past 10 Years
Min: 96.03 Med: 104.85 Max: 221.24
Current: 221.24
During the past 9 years, Vineet Laboratories's highest Days Payable was 221.24. The lowest was 96.03. And the median was 104.85.
NSE:VINEETLAB's Days Payable is ranked better than 94.92% of 1556
companies
in the Chemicals industry
Industry Median: 59.915
vs NSE:VINEETLAB: 221.24
Vineet Laboratories's Days Payable
increased
from Dec. 2024 (144.06) to Dec. 2025 (265.37).
It may suggest that Vineet Laboratoriesdelayed paying its suppliers.
Vineet Laboratories Days Payable Related Terms
Vineet Laboratories Days Payable Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Vineet Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vineet Laboratories's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) has a Days Payable of 265.37 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vineet Laboratories and its competitors. This is 153% above median its historical median of 104.85. Over the past decade, Vineet Laboratories' Days Payable has ranged from 96.03 to 221.24. According to the industry distribution chart, Vineet Laboratories ranks #79 out of 1556 companies in the Chemicals industry, placing it in the top 5.1%.
Is Vineet Laboratories' Days Payable too high?
Vineet Laboratories' current Days Payable of 265.37 is 153% above median its 10-year median of 104.85. Over the past 10 years, this metric has ranged from a low of 96.03 to a high of 221.24. The Chemicals industry median Days Payable is 59.92. Vineet Laboratories' value of 265.37 is 342.9% above this industry median. Based on the distribution chart, Vineet Laboratories ranks #79 out of 1556 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Days Payable compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #79 out of 1556 companies for Days Payable. This places Vineet Laboratories in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.92. Vineet Laboratories' value of 265.37 is 342.9% above this benchmark. Historically, Vineet Laboratories' own Days Payable has ranged from 96.03 to 221.24 over the past decade. While the company's 10-year median is 104.85 vs. the industry median of 59.92, Vineet Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.92, based on 1,556 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current Days Payable of 265.37 is 342.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median Days Payable is 59.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Days Payable is 265.37, which is 153% above median its own 10-year median of 104.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.48, compared to a current price of ₹33.34 — trading 115.4% above its estimated fair value. The current Days Payable is 265.37, which is 153% above median its 10-year median of 104.85 and 342.9% above the Chemicals industry median of 59.92. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Days Payable is 265.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹33.34 is trading 115.4% above its estimated GF Value™ of ₹15.48.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Days Payable: 265.37 (153% above median its 10-year median of 104.85)
GF Value™: ₹15.48 vs. price of ₹33.34 (115.4% above fair value)
Industry Position: 342.9% above the Chemicals median (#79 of 1556)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score
Get the complete analysis for NSE:VINEETLAB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
